First-line therapy in relapsing remitting multiple sclerosis.
Sign Up to like & getrecommendations! Published in 2018 at "Revue neurologique"
DOI: 10.1016/j.neurol.2018.03.012
Abstract: Today, first-line treatments for multiple sclerosis include injectable immunomodulators - some of which have been on the market for nearly 25 years - as well as teriflunomide and dimethyl fumarate, which are more recent, but… read more here.
Keywords: line; first line; multiple sclerosis; therapy relapsing ... See more keywords
Biologic therapy in relapsing polychondritis: navigating between options
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2022.2048647
Abstract: ABSTRACT Introduction Relapsing polychondritis (RP) is a rare systemic inflammatory disease of unknown etiology, primarily affecting cartilaginous tissue and proteoglycan-rich structures. Clinical manifestations vary from mild symptoms to occasional organ or life-threatening complications. Treatment can… read more here.
Keywords: biologic therapy; relapsing polychondritis; therapy; therapy relapsing ... See more keywords